LVAEX
Price
$27.97
Change
-$0.77 (-2.68%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

LVAEX vs RMFCX

Header iconLVAEX vs RMFCX Comparison
Open Charts LVAEX vs RMFCXBanner chart's image
LSV Value Equity Investor
Price$27.97
Change-$0.77 (-2.68%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
LVAEX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LVAEX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVAEX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. LVAEX (1.38B). LVAEX pays higher dividends than RMFCX: LVAEX (1.78) vs RMFCX (1.69). LVAEX was incepted earlier than RMFCX: LVAEX (11 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. LVAEX (10.00). RMFCX has a lower initial minimum investment than LVAEX: RMFCX (250) vs LVAEX (1000). LVAEX annual gain was more profitable for investors over the last year : 11.20 vs. RMFCX (9.39). RMFCX return over 5 years is better than : 36.51 vs. LVAEX (14.28).
LVAEXRMFCXLVAEX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD15.6078.896175%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B98.7B1%
Annual Yield % from dividends1.781.69105%
Returns for 1 year11.209.39119%
Returns for 3 years-3.9611.57-34%
Returns for 5 years14.2836.5139%
Returns for 10 years42.5958.1773%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc